Skip to main content
Acta Histochemica et Cytochemica logoLink to Acta Histochemica et Cytochemica
. 2023 Apr 25;56(2):39. doi: 10.1267/ahc.23-00024RT

Retraction: Dexmedetomidine and Phosphocreatine Post-treatment Provides Protection against Focal Cerebral Ischemia-reperfusion Injury in Rats

PMCID: PMC10139839  PMID: 37124955

Acta Histochem. Cytochem. 54, 105–113 (2021)

Retraction: Dexmedetomidine and Phosphocreatine Post-treatment Provides Protection against Focal Cerebral Ischemia-reperfusion Injury in Rats

Xiaofen Sun, Fang Kang, Yuxian Shen, Yujun Shen and Juan Li

The following article by X. Sun, F. Kang, Y. Shen, Y. Shen, and J. Li: Dexmedetomidine and Phosphocreatine Post-treatment Provides Protection against Focal Cerebral Ischemia-reperfusion Injury in Rats in Acta Histochem. Cytochem. 54 105–113 (2021) has been retracted because of an intolerable misconduct by the author after its publication. Despite of several warnings by the Editorial Board, the authors did not take any appropriate measures, and therefore the Editorial Board decided to retract the article.


Articles from Acta Histochemica et Cytochemica are provided here courtesy of Japan Society of Histochemistry and Cytochemistry

RESOURCES